期刊文献+

HPLC法测定人血浆中艾美拉唑的浓度 被引量:2

Determination of Esomeprazole in Human Plasma by HPLC
原文传递
导出
摘要 目的:建立以高效液相色谱法测定人血浆中艾美拉唑浓度的方法。方法:血浆以乙腈沉淀蛋白,上清液与二氯甲烷混合离心后,取上层水相进样分析。其中,色谱柱为Zobax Rx-Sil柱,流动相为甲醇,流速为1·5mL·min-1,紫外检测波长为306nm,内标为非那西丁,柱温为28℃。结果:艾美拉唑检测浓度在0·05~4·0mg·L-1范围内与峰面积积分值线性关系良好(r=0·9997),日内RSD为2·04%~2·91%,最低检测限为0·05mg·L-1,平均回收率为95·80%。结论:本方法取样量小、操作快速简便、灵敏度高,可为进一步开展生物等效性研究奠定基础。 OBJECTIVE:To develop a HPLC method for the determination of esomeprazole in human plasma.METHODS: The plasma sample was extracted with dichloromethane, after centrifugation of the mixture of supernatant fluid and dichlormethane, the upper layer aqueous phase was taken for analysis.The separation was performed on Zobax Rx-Si column with mobile phase consisted of MeOH at a flow rate of 1.SmL · min^ -1.The detection wavelength was 306nm, the internal standard was phenacetin and the column temperature was 28℃ .RESULTS: The calibration curves were linear in the range of 0.05-4.0mg · L^-1 for esomeprazole(r = 0.999 7) .The intra- day RSD was 2.04--2.91%; the lowest detectable limit was 0.05mg ·L^-1 and the average recovery of esomeprazole was 95.80 %. CONCLUSION : The method is rapid, simple, specific and sensitive, in which the sample needed for determination is small.It serves as a foundation for the bioequiavailability study of esomeprazole.
出处 《中国药房》 CAS CSCD 北大核心 2007年第14期1071-1072,共2页 China Pharmacy
关键词 艾美拉唑 高效液相色谱法 血浆 浓度 Esomeprazole HPLC Plasma Concentration
  • 相关文献

参考文献6

二级参考文献5

共引文献39

同被引文献22

  • 1丁晓虎,沈晓琴.埃索美拉唑与奥美拉唑治疗反流性食管炎及治愈后维持的成本-效果分析[J].中国药房,2006,17(14):1070-1072. 被引量:15
  • 2Cotton H, Elebring T, Larsson M, et al. Asymmetric synthesis of esomeprazole[J ]. Tetrahedron : Asymmetry, 2000, 11(18): 3 819.
  • 3Cotton H, Kronstr6m A, Mattson A, et al. Form of S - Omeprazole [ P ].US Patent, 6369085.2002- 04- 09.
  • 4Lindberg PL, Gundas GS, Vonunge S. Optically pure salts of pyridinylmethyl sulfinyl - 1H - Benzimida- zole compounds [ P ] . W.O. Patent, 9427988.1994 - 12- 08.
  • 5Lindberg PL, Sverker U. Compositions [P]. US. Patent, 5714504.1998- 02- 03.
  • 6Lindberg PL, Sverker U. Compounds [P] .US. Patent, 6143771.2000- 11 - 07.
  • 7Xie Y, Xie P, Song X, et al. Preparation of esomeprazole zinc solid dispersion and study on its pharmacokinetics[ J ]. Int J Phar m, 2008,360( 1-- 2) : 53.
  • 8梁小燕,高青,龚能平,汤丽平,王丕龙,陶小红.埃索美拉唑肠溶胶囊治疗幽门螺杆菌疗效观察[J].中国药房,2007,18(26):2044-2046. 被引量:5
  • 9Kim JG. Treatment of Helicobacter pylori infection [ J ]. Korean J Gastroentero1,2005,46(3 ) :172 - 180.
  • 10Dupas JL. First line therapy for Helicobacter pylori eradication in France [ J ]. Gastroenterol Clin Biol,2003,27 ( 3 ) :467 - 472.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部